302 related articles for article (PubMed ID: 33450506)
1. BIRD-2, a BH4-domain-targeting peptide of Bcl-2, provokes Bax/Bak-independent cell death in B-cell cancers through mitochondrial Ca
Kerkhofs M; La Rovere R; Welkenhuysen K; Janssens A; Vandenberghe P; Madesh M; Parys JB; Bultynck G
Cell Calcium; 2021 Mar; 94():102333. PubMed ID: 33450506
[TBL] [Abstract][Full Text] [Related]
2. Constitutive IP
Bittremieux M; La Rovere RM; Akl H; Martines C; Welkenhuyzen K; Dubron K; Baes M; Janssens A; Vandenberghe P; Laurenti L; Rietdorf K; Morciano G; Pinton P; Mikoshiba K; Bootman MD; Efremov DG; De Smedt H; Parys JB; Bultynck G
Cell Death Differ; 2019 Mar; 26(3):531-547. PubMed ID: 29899382
[TBL] [Abstract][Full Text] [Related]
3. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
[TBL] [Abstract][Full Text] [Related]
4. HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP 3 receptor / Bcl-2 complexes.
Akl H; La Rovere RM; Janssens A; Vandenberghe P; Parys JB; Bultynck G
Int J Dev Biol; 2015; 59(7-9):391-8. PubMed ID: 26260683
[TBL] [Abstract][Full Text] [Related]
5. Reciprocal sensitivity of diffuse large B-cell lymphoma cells to Bcl-2 inhibitors BIRD-2 versus venetoclax.
Vervloessem T; Akl H; Tousseyn T; De Smedt H; Parys JB; Bultynck G
Oncotarget; 2017 Dec; 8(67):111656-111671. PubMed ID: 29340082
[TBL] [Abstract][Full Text] [Related]
6. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
[TBL] [Abstract][Full Text] [Related]
7. IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2.
Akl H; Monaco G; La Rovere R; Welkenhuyzen K; Kiviluoto S; Vervliet T; Molgó J; Distelhorst CW; Missiaen L; Mikoshiba K; Parys JB; De Smedt H; Bultynck G
Cell Death Dis; 2013 May; 4(5):e632. PubMed ID: 23681227
[TBL] [Abstract][Full Text] [Related]
8. Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation.
Hamacher-Brady A; Brady NR
J Biol Chem; 2015 Sep; 290(36):22005-18. PubMed ID: 26134559
[TBL] [Abstract][Full Text] [Related]
9. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2.
Lavik AR; Zhong F; Chang MJ; Greenberg E; Choudhary Y; Smith MR; McColl KS; Pink J; Reu FJ; Matsuyama S; Distelhorst CW
Oncotarget; 2015 Sep; 6(29):27388-402. PubMed ID: 26317541
[TBL] [Abstract][Full Text] [Related]
10. Cancer cell death strategies by targeting Bcl-2's BH4 domain.
de Ridder I; Kerkhofs M; Veettil SP; Dehaen W; Bultynck G
Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118983. PubMed ID: 33549704
[TBL] [Abstract][Full Text] [Related]
11. BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models.
Vervloessem T; Sasi BK; Xerxa E; Karamanou S; Kale J; La Rovere RM; Chakraborty S; Sneyers F; Vogler M; Economou A; Laurenti L; Andrews DW; Efremov DG; Bultynck G
Cell Death Dis; 2020 Sep; 11(9):769. PubMed ID: 32943617
[TBL] [Abstract][Full Text] [Related]
12. Regulated necrotic cell death: the passive aggressive side of Bax and Bak.
Karch J; Molkentin JD
Circ Res; 2015 May; 116(11):1800-9. PubMed ID: 25999420
[TBL] [Abstract][Full Text] [Related]
13. Targeting Bcl-2-IP
Distelhorst CW
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
[TBL] [Abstract][Full Text] [Related]
14. Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263.
Greenberg EF; McColl KS; Zhong F; Wildey G; Dowlati A; Distelhorst CW
Cell Death Dis; 2015 Dec; 6(12):e2034. PubMed ID: 26720343
[TBL] [Abstract][Full Text] [Related]
15. Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death.
Karch J; Kanisicak O; Brody MJ; Sargent MA; Michael DM; Molkentin JD
PLoS One; 2015; 10(6):e0130520. PubMed ID: 26061004
[TBL] [Abstract][Full Text] [Related]
16. Calpain and reactive oxygen species targets Bax for mitochondrial permeabilisation and caspase activation in zerumbone induced apoptosis.
Sobhan PK; Seervi M; Deb L; Varghese S; Soman A; Joseph J; Mathew KA; Raghu G; Thomas G; E S; S M; R SK
PLoS One; 2013; 8(4):e59350. PubMed ID: 23593137
[TBL] [Abstract][Full Text] [Related]
17. Extracellular and ER-stored Ca
Bittremieux M; La Rovere RM; Schuermans M; Luyten T; Mikoshiba K; Vangheluwe P; Parys JB; Bultynck G
Cell Death Discov; 2018; 4():101. PubMed ID: 30416758
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL acts as an inhibitor of IP
Rosa N; Ivanova H; Wagner LE; Kale J; La Rovere R; Welkenhuyzen K; Louros N; Karamanou S; Shabardina V; Lemmens I; Vandermarliere E; Hamada K; Ando H; Rousseau F; Schymkowitz J; Tavernier J; Mikoshiba K; Economou A; Andrews DW; Parys JB; Yule DI; Bultynck G
Cell Death Differ; 2022 Apr; 29(4):788-805. PubMed ID: 34750538
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the Anti-Apoptotic Bcl-2 Family by BH3 Mimetics Sensitize the Mitochondrial Permeability Transition Pore Through Bax and Bak.
Patel P; Mendoza A; Robichaux DJ; Wang MC; Wehrens XHT; Karch J
Front Cell Dev Biol; 2021; 9():765973. PubMed ID: 34926454
[TBL] [Abstract][Full Text] [Related]
20. BH3 peptides induce mitochondrial fission and cell death independent of BAX/BAK.
Shroff EH; Snyder CM; Budinger GR; Jain M; Chew TL; Khuon S; Perlman H; Chandel NS
PLoS One; 2009 May; 4(5):e5646. PubMed ID: 19468307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
